Bard Groshong Midline is a peripherally inserted central catheter designed for short term (less than 30 days) vascular access. It features a patented Groshong valve that prevents blood backflow and air embolism, eliminating the need for heparin flushing. The catheter is made from specially formulated medical-grade materials and is available in various sizes to accommodate different patient needs. The Groshong Midline is ideal for delivering selected infusates, including those with high glucose or protein concentrations. It is contraindicated for continuous infusion of vesicants.
Bard Groshong Midline is a peripherally inserted central catheter designed for short term (less than 30 days) vascular access. It features a patented Groshong valve that prevents blood backflow and air embolism, eliminating the need for heparin flushing. The catheter is made from specially formulated medical-grade materials and is available in various sizes to accommodate different patient needs. The Groshong Midline is ideal for delivering selected infusates, including those with high glucose or protein concentrations. It is contraindicated for continuous infusion of vesicants.
Bard Groshong Midline is a peripherally inserted central catheter designed for short term (less than 30 days) vascular access. It features a patented Groshong valve that prevents blood backflow and air embolism, eliminating the need for heparin flushing. The catheter is made from specially formulated medical-grade materials and is available in various sizes to accommodate different patient needs. The Groshong Midline is ideal for delivering selected infusates, including those with high glucose or protein concentrations. It is contraindicated for continuous infusion of vesicants.
Ask a question and I''ll find the answer in the document
Finding information in a document is now easier with AI